NCT05249335View on ClinicalTrials.gov

Comparison for Efficacy and Safety of Bowel Preparation Between Oral Sulfate Table and 2L-polyethylene Glycol/Ascorbate in Elderly

PHASE4UnknownINTERVENTIONAL
Enrollment

256

Participants

Timeline

Start Date

February 28, 2022

Primary Completion Date

February 29, 2024

Study Completion Date

February 29, 2024

Conditions
Colonic DiseaseIntestinal Disease
Interventions
DRUG

OST

The subject will receive Orafang for colonoscopy

DRUG

2L-PEG/Asc

The subject will receive 2L-PEG/Asc for colonoscopy

Sponsors
All Listed Sponsors
lead

Pharmbio Korea Co., Ltd.

INDUSTRY

NCT05249335 - Comparison for Efficacy and Safety of Bowel Preparation Between Oral Sulfate Table and 2L-polyethylene Glycol/Ascorbate in Elderly | Biotech Hunter | Biotech Hunter